Senior insider sale
See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$8.98M
515.54K shares
What this filing means
SABAG MARK plans to sell 515.54K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $8.98M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/8/2025ACC: 0001973379-25-000149
Officer· See "Remarks"
Since Mar 2026
515.54K
Shares to sell
$8.98M
Approx. market value
337.92K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
SHARES FROM ROLLOVER
COMPENSATION
3/6/2023
337.92KTotal acquired337.92K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/6/2023 | SHARES FROM ROLLOVER COMPENSATION | 337.92K | — |
| Total | 337.92K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
177.63K
Market value
$2.89M
2/12/2025
Planned — Approximate Date
NYSEPlanned
Units to sell
337.92K
Market value
$6.10M
5/8/2025
Total
Units
515.54K
Value
$8.98M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/12/2025 | 177.63K | $2.89M | — | Completed |
| Planned — Approximate Date | ||||
5/8/2025 | 337.92K | $6.10M | NYSE | Planned |
| Total | 515.54K | $8.98M | ||